文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

吸烟暴露人群中自杀或药物过量死亡风险相关的临床标志物:COPDGene 队列纵向随访研究

Clinical Markers Associated With Risk of Suicide or Drug Overdose Among Individuals With Smoking Exposure: A Longitudinal Follow-up Study of the COPDGene Cohort.
PubMed 文献 · Chest · 2022-09-24
一句话结论在吸烟暴露人群中,当前吸烟、使用镇静催眠药和呼吸困难与自杀/药物过量死亡风险升高相关,而气流受限严重程度与风险无关。

该研究基于 COPDGene 多中心前瞻性队列中 9930 名吸烟暴露个体的数据,以自杀/药物过量死亡为主要结局,采用 Cox 回归模型(含时变协变量,其他死因作为竞争风险)分析临床预测因素。共 63 人死于自杀/药物过量。当前吸烟(HR 6.44;95%CI 2.64-15.67)、使用镇静催眠药(HR 2.33;95%CI 1.24-4.38)和呼吸困难(mMRC≥2,HR 2.23;95%CI 1.34-3.70)与风险升高相关;年龄较大(每十年 HR 0.45;95%CI 0.31-0.67)、较高 BMI(HR 0.95;95%CI 0.91-0.99)和非裔美国人种族(HR 0.41;95%CI 0.23-0.74)与风险降低相关。气流受限严重程度(FEV1%预计值)与自杀风险无关。作者认为,风险因素强调了疾病的主观体验而非肺功能的客观评估。

要点

  • 当前吸烟与自杀/药物过量死亡风险升高相关(HR 6.44;95%CI 2.64-15.67)。
  • 使用镇静催眠药与风险升高相关(HR 2.33;95%CI 1.24-4.38)。
  • 呼吸困难(mMRC≥2)与风险升高相关(HR 2.23;95%CI 1.34-3.70)。
  • 年龄较大(每十年 HR 0.45;95%CI 0.31-0.67)、较高 BMI(HR 0.95;95%CI 0.91-0.99)和非裔美国人种族(HR 0.41;95%CI 0.23-0.74)与风险降低相关。
  • 气流受限严重程度(FEV1%预计值)与自杀风险无关。

适用人群与场景

  • COPDGene 研究中 9930 名吸烟暴露个体,包括肺功能正常至重度 COPD 的疾病谱。
  • 队列特征:47% 女性,33% 黑人(67% 白人),平均年龄 59.6±9.0 岁,平均 FEV1%预计值 76.1±25.5。

研究设计与关键结果

  • 研究类型:多中心前瞻性队列研究(COPDGene),样本量 9930 名吸烟暴露个体。
  • 主要结局:自杀/药物过量死亡,共 63 例;采用 Cox 回归模型(含时变协变量,其他死因作为竞争风险)分析。
  • 当前吸烟者自杀/药物过量死亡风险升高(HR 6.44;95%CI 2.64-15.67)。
  • 使用镇静催眠药者风险升高(HR 2.33;95%CI 1.24-4.38)。
  • 呼吸困难(mMRC≥2)者风险升高(HR 2.23;95%CI 1.34-3.70)。
  • 年龄较大者风险降低(每十年 HR 0.45;95%CI 0.31-0.67)。
  • BMI 较高者风险降低(HR 0.95;95%CI 0.91-0.99)。
  • 非裔美国人种族风险降低(HR 0.41;95%CI 0.23-0.74)。

证据类型、等级与局限

  • 证据类型:多中心前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在吸烟暴露人群中,评估自杀/药物过量风险时应关注当前吸烟、镇静催眠药使用和呼吸困难(mMRC≥2)等临床因素,而非仅依据气流受限严重程度。
  • 作者认为,风险因素强调了疾病的主观体验而非肺功能的客观评估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Studies have shown that COPD and smoking are associated with increased suicide risk. To date, there are no prospective studies examining suicide risk among individuals with smoking exposure along a spectrum of pulmonary diseases ranging from normal spirometry to severe COPD.

RESEARCH QUESTION: Which clinical variables predict death by suicide or overdose of indeterminate intent in a large cohort of individuals with smoking exposure within the Genetic Epidemiology of COPD (COPDGene) study?

STUDY DESIGN AND METHODS: We studied data from 9,930 participants involved in COPDGene, a multisite, prospective cohort study of individuals with smoking exposure. Primary cause of adjudicated deaths was identified by using death certificates, family reports, and medical records. Time to death by suicide/overdose was examined as the primary outcome in Cox regression models including age, sex, race, BMI, pack-years, current smoking status, airflow limitation (FEV1 % predicted), dyspnea (modified Medical Research Council scale score ≥ 2), 6-min walk distance, supplemental oxygen use, and severe exacerbations in the prior year with time-varying covariates and other causes of death as a competing risk.

RESULTS: The cohort was 47% female and 33% Black (67% White); they had a mean ± SD age of 59.6 ± 9.0 years and a mean FEV1 % predicted of 76.1 ± 25.5. Sixty-three individuals died by suicide/overdose. Factors associated with risk of suicide/overdose were current smoking (hazard ratio [HR], 6.44; 95% CI, 2.64-15.67), use of sedative/hypnotics (HR, 2.33; 95% CI, 1.24-4.38), and dyspnea (HR, 2.23; 95% CI, 1.34-3.70). Lower risk was associated with older age (per-decade HR, 0.45; 95% CI, 0.31-0.67), higher BMI (HR, 0.95; 95% CI, 0.91-0.99), and African-American race (HR, 0.41; 95% CI, 0.23-0.74). Severity of airflow limitation (FEV % predicted) was not associated with suicide risk.

INTERPRETATION: In this well-characterized cohort of individuals with smoking exposure with and without COPD, risk factors for suicide/overdose were identified that emphasize the subjective experience of illness over objective assessments of lung function.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Adviento BA, Regan EA, Make BJ, et al. Clinical Markers Associated With Risk of Suicide or Drug Overdose Among Individuals With Smoking Exposure: A Longitudinal Follow-up Study of the COPDGene Cohort. Chest. 2022. PMID: 36167120. doi:10.1016/j.chest.2022.09.022

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。